Non-Hodgkin Lymphoma

Using HDAC3 Inhibitors to Reverse CREBBP Mutations in Lymphomas
January 13, 2020
ByHannah Slater

This research could potentially pave the way for possible immunotherapy approaches for common forms of non-Hodgkin lymphoma.

CAR T-Cell Therapy Studies to Look for at the ASH Annual Meeting
November 27, 2019
ByKristie L. Kahl

Research on chimeric antigen receptor T-cell therapy to be presented at the ASH Annual Meeting & Exposition is set to address drawbacks associated with treatment.

Recent Research on Diabetes Mellitus, Non-Hodgkin Lymphoma Link
October 18, 2019
ByLeanne Marcello, MS

After conflicting opinions over the years, a study published in the journal Hematology explores the association between diabetes mellitus non-hodgkin lymphoma.